Amin Sharifan, PharmD

Abdulazeem, H.; Borges do Nascimento, I.J.; Weerasekara, I.; Sharifan, A.; Grandi Bianco, V.; Cunningham, C.; Kularathne, I.; Deeken, G.; de Barros, J.; Sathian, B.; Østengaard, L.; Lamontagne-Godwin, F.; van Hoof, J.; Lazeri, L.; Redlich, C.; Marston, H.R.; Alistair Dos Santos, R.; Azzopardi-Muscat, N.; Yon, Y.; Novillo-Ortiz, D. (2025). Use of Digital Health Technologies for Dementia Care: Bibliometric Analysis and Report. JMIR Ment Health, 12:e64445: 10.2196/64445

GBD 2021 Europe Life Expectancy Collaborators; Steel, N., Sharifan, A. (2025). Changing life expectancy in European countries 1990–2021: a subanalysis of causes and risk factors from the Global Burden of Disease Study 2021. Lancet Public Health, 10: e172–88

GBD 2021 Suicide Collaborators; Davis Weaver, N.; Sharifan, A.; (2025). Global, regional, and national burden of suicide, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Public Health, 10: e189-e202

Li, S.; Zhang, L.; Wang, Y.; Xie, R.; Chen, W.; Soo Lee, M.; Amer, Y.S.; Sharifan, A.; Hussein, H.; Li, H. (2025). Development and validation a methodology model for traditional Chinese medicine good practice recommendation: an exploratory sequential mixed methods study. Frontiers in Pharmacology, 16:1501634: 10.3389/fphar.2025.1501634

Sharifan, A. (2025). Oncolytic Virotherapy in Otorhinolaryngologic Neoplasms: A Scoping Review and Bibliometric Analysis. American Journal of Therapeutics, 10.1097/MJT.0000000000001876: 10.1097/MJT.0000000000001876

Sharifan, A.; Abdulazeem, H.; Meckawy, R.; Sonkoue Pianta, M.; Abdelwahab, M.M.; Halder, A.; Gust Duque, T.; (2025). Appraisal of World Health Organization guidelines for priority infectious diseases with potential to cause public health emergencies. Public Health, 240: 112-118

Sharifan, A. (2025). How does uterine curettage (with or without subsequent adjuvant chemotherapy) compare with primary chemotherapy alone for women with post-molar low-risk, non-metastatic gestational trophoblastic neoplasia? Cochrane Clinical Answers, https://doi.org/10.1002/cca.4514: https://doi.org/10.1002/cca.4514

Sharifan, A. (2025). Can smoking cessation interventions initiated during hospitalization help adults admitted for medical or surgical care to quit smoking? Cochrane Clinical Answers, https://doi.org/10.1002/cca.4529: https://doi.org/10.1002/cca.4529

Sharifan, A. (2025). What are the benefits and harms of classical psychedelics (psilocybin and LSD) for treating anxiety, depression, and existential distress in people with life-threatening diseases? Cochrane Clinical Answers, https://doi.org/10.1002/cca.4512: https://doi.org/10.1002/cca.4512

Sharifan, A. (2025). How does continuous infusion compare with bolus injection of furosemide for adults with acute decompensated heart failure? Cochrane Clinical Answers, https://doi.org/10.1002/cca.4455: https://doi.org/10.1002/cca.4455

Sharifan, A. (2025). How does the addition of immune checkpoint inhibitors (ICIs) to platinum-based chemotherapy compare with platinum-based chemotherapy alone as a first-line treatment for older adults with non-small cell lung cancer (NSCLC)? Cochrane Clinical Answers, https://doi.org/10.1002/cca.4509: https://doi.org/10.1002/cca.4509

Sharifan, A. (2025). How do implant-based and autologous tissue-based reconstruction techniques compare for women undergoing breast reconstruction after mastectomy? Cochrane Clinical Answers, https://doi.org/10.1002/cca.4543: https://doi.org/10.1002/cca.4543

Sharifan, A. (2025). For adults with cancer, what are the benefits and harms of resistance training (either during or after anticancer therapy)? Cochrane Clinical Answers, https://doi.org/10.1002/cca.4547: https://doi.org/10.1002/cca.4547

Sharifan, A. (2025). What are the effects of interventions to improve healthcare professionals' reporting of adverse drug reactions and medication errors? Cochrane Clinical Answers, https://doi.org/10.1002/cca.4537: https://doi.org/10.1002/cca.4537

Sharifan, A.; (2025). What are the effects of disulfiram for adults with cocaine dependence? Cochrane Clinical Answers, https://doi.org/10.1002/cca.4524: https://doi.org/10.1002/cca.4524

Sharifan, A.; Saee, S. (2025). How do lower blood pressure targets (= 130/80 mmHg) compare with higher targets (= 140 to 160/90 to 100 mmHg) for adults with chronic kidney disease (CKD) and hypertension? Cochrane Clinical Answers, 10.1002/cca.4548: 10.1002/cca.4548

GBD 2021 Antimicrobial Resistance Collaborators; Sharifan, A. (2024). Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050. The Lancet, Volume 404, Issue 10459: p1199-1226

GBD 2021 Diarrhoeal Diseases Collaborators; Sharifan, A. (2024). Global, regional, and national age-sex-specific burden of diarrhoeal diseases, their risk factors, and aetiologies, 1990–2021, for 204 countries and territories: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Infect Dis, Published Online: https://doi.org/10.1016/ S1473-3099(24)00691-1

GBD 2021 HIV Collaborators; Sharifan, A. (2024). Global, regional, and national burden of HIV/AIDS, 1990–2021, and forecasts to 2050, for 204 countries and territories: the Global Burden of Disease Study 2021. The Lancet HIV, 11, Issue 12: e807-e822

GBD 2021 Stroke Risk Factor Collaborators; Sharifan, A. (2024). Global, regional, and national burden of stroke and its risk factors, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. The Lancet Neurology, Volume 23, Issue 10: 973 - 1003